Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17081
-
17082
-
17083
Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2′-Deoxycytidine Results in Increased Tumorigenicity
Published 2009“…To examine its effect on tumorigenesis, we induced DNA demethylation in a rat model of human chondrosarcoma using 5-aza-2-deoxycytidine. …”
-
17084
-
17085
-
17086
-
17087
-
17088
Encapsulation studies with 5(6)-Carboxyfluorescein.
Published 2013“…<p>(A) 5(6)-Carboxyfluorescein loaded peptide vesicles were prepared in different ethanol concentrations and separated over 30 kDa MWCO filters. …”
-
17089
Ultrafast Light-Driven Nanomotors Based on an Acridane Stator
Published 2010“…The introduction of a cyclopentanylidene rotor unit results in a decrease in steric hindrance with respect to the stator, and as a consequence, a 10<sup>12</sup>-fold increase in the rate of thermal helix inversion is observed. …”
-
17090
-
17091
-
17092
-
17093
-
17094
-
17095
-
17096
-
17097
-
17098
-
17099
DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx
Published 2024“…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”
-
17100
DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx
Published 2024“…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”